Volcano's Revolution rotational IVUS (intravascular ultrasound) cleared for sale in Japan:
This article was originally published in Clinica
Following last month's Japanese approval for its s5i integrated IVUS (intravascular ultrasound) device (see Clinica No 1267, p 16), Volcano has received approval in the same country to market its Revolution 45 MHz rotational IVUS imaging catheter. The new approval covers use of the Revolution catheter - the highest frequency IVUS catheter available in Japan - on Volcano's IVG IVUS system. The Rancho Cordova, California firm has scheduled the Japanese launch of the catheter during the fourth quarter of this year. The Revolution catheter is already available in the US and Europe.
You may also be interested in...
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.